Status:

COMPLETED

Predictors of Lactogenesis II

Lead Sponsor:

University of South Florida

Conditions:

Breastfeeding

Eligibility:

FEMALE

18-50 years

Brief Summary

The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypoth...

Detailed Description

Lactogenesis I occurs during pregnancy (midpregnancy and beyond), when the mammary glands becomes sufficiently differentiated to secrete small quantities of specific milk components. Lactogenesis II i...

Eligibility Criteria

Inclusion

  • intend to attempt breastfeeding
  • Expecting a live-born infant
  • Singleton pregnancy
  • English or Spanish language fluency
  • Delivered at fullterm gestation

Exclusion

  • Multiple gestation delivery
  • Delivered pre-term (\<36weeks and 6 days of gestation)
  • Not admitted to Mother Baby Unit (MBU) (ie admitted to intensive or special care unit or to Labor \& Delivery Unit for postpartum monitoring)
  • Mother did not initiate breastfeeding within 12 hours.
  • No telephone access
  • History of breast reduction or enlargement surgery
  • Planning to formula feed from birth (no intention to breastfeed or try breastfeeding).

Key Trial Info

Start Date :

August 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2017

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT02220413

Start Date

August 1 2014

End Date

January 1 2017

Last Update

September 21 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Tampa General Hospital

Tampa, Florida, United States, 33606

2

USF South Tampa Center

Tampa, Florida, United States, 33606

3

TGH Health Park Genesis Clinic

Tampa, Florida, United States, 33610